Another malaria drug from CDRI
The Central Drug Research Institute (CDRI) has entered into an agreement for development of a promising synthetic substitute for an anti-malaria drug based on artemisinin derived from Artemisia
The Central Drug Research Institute (CDRI) has entered into an agreement for development of a promising synthetic substitute for an anti-malaria drug based on artemisinin derived from Artemisia